---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-019540"
form_type: "8-K"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2024-03-04T23:59:59+00:00"
generated_at: "2026-06-05T05:01:39.443656+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Allarity Therapeutics terminates Chief Medical Officer Marie Foegh, effective Feb 29

## Summary
- Marie Foegh, M.D., terminated as Chief Medical Officer on Feb 28, 2024.
- Her last day of employment was Feb 29, 2024.
- No replacement or interim appointment announced.
- Ticker ALLR; small-cap biotech with key leadership vacancy.

## SEC filing metadata
- accession: 0001213900-24-019540
- form_type: 8-K
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2024-03-04T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000121390024019540/0001213900-24-019540-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000121390024019540/ea0201126-8k_allarity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-019540
- JSON: https://secwatch.observer/filing/0001213900-24-019540.json
- Plain text: https://secwatch.observer/filing/0001213900-24-019540.txt

## Key facts
- Executive change
  Marie Foegh was terminated as Chief Medical Officer at Allarity Therapeutics, Inc..
  - Action: terminated
  - Role: Chief Medical Officer
  source text: On February 28, 2024, Allarity Therapeutics, Inc. (the “Company”) terminated the employment of Marie Foegh, M.D., the Company’s Chief Medical Officer. Ms. Foegh’s last day of employment was February 29, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860657/000121390024019540/0001213900-24-019540-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.